17-59964660-G-C
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_016125.4(RNFT1):āc.4C>Gā(p.Pro2Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000436 in 1,606,150 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_016125.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RNFT1 | NM_016125.4 | c.4C>G | p.Pro2Ala | missense_variant | 1/9 | ENST00000305783.13 | NP_057209.3 | |
TBC1D3P1-DHX40P1 | NR_002924.3 | n.1207-1376C>G | intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RNFT1 | ENST00000305783.13 | c.4C>G | p.Pro2Ala | missense_variant | 1/9 | 1 | NM_016125.4 | ENSP00000304670 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000132 AC: 2AN: 152074Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000173 AC: 4AN: 231506Hom.: 0 AF XY: 0.00000790 AC XY: 1AN XY: 126592
GnomAD4 exome AF: 0.00000344 AC: 5AN: 1454076Hom.: 0 Cov.: 31 AF XY: 0.00000138 AC XY: 1AN XY: 722780
GnomAD4 genome AF: 0.0000132 AC: 2AN: 152074Hom.: 0 Cov.: 31 AF XY: 0.00 AC XY: 0AN XY: 74298
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 04, 2024 | The c.4C>G (p.P2A) alteration is located in exon 1 (coding exon 1) of the RNFT1 gene. This alteration results from a C to G substitution at nucleotide position 4, causing the proline (P) at amino acid position 2 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at